US 8809291
Id-1 gene and gene products as therapeutic targets for treatment of breast cancer and other types of carcinoma
granted A61PA61P35/00
Quick answer
US patent 8809291 (Id-1 gene and gene products as therapeutic targets for treatment of breast cancer and other types of carcinoma) held by The Regents of the University of California expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Aug 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61P, A61P35/00